<p>Everolimus is indicated in advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer (Advanced HR+ BC),&nbsp;Advanced Neuroendocrine Tumors (NET);&nbsp;Advanced Renal Cell Carcinoma (RCC);&nbsp;Renal Angiomyolipoma With Tuberous Sclerosis Complex (TSC);&nbsp;Subependymal Giant Cell Astrocytoma (SEGA) With Tuberous Sclerosis Complex (TSC)<br />
<br />
In combination with ciclosporin for microemulsion &amp; corticosteroids for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant. In combination with tacrolimus &amp; corticosteroids for the prophylaxis of organ rejection in patients receiving hepatic transplant.</p>